Jack Nathan Medical Corp.
JNH.V
TSX
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 27.09% | -93.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.09% | -93.27% | |||
| Cost of Revenue | 4.95% | 164.63% | |||
| Gross Profit | 81.44% | -101.52% | |||
| SG&A Expenses | 22.96% | -86.61% | |||
| Depreciation & Amortization | 3.73% | 120.86% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.17% | -70.64% | |||
| Operating Income | -10.25% | -174.23% | |||
| Income Before Tax | 44.17% | -149.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.17% | -150.07% | |||
| Earnings from Discontinued Operations | 138.13% | -105.50% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 95.74% | -109.19% | |||
| EBIT | -10.25% | -174.23% | |||
| EBITDA | -12.65% | -163.15% | |||
| EPS Basic | 95.18% | -109.16% | |||
| Normalized Basic EPS | 43.48% | -145.10% | |||
| EPS Diluted | 95.83% | -110.57% | |||
| Normalized Diluted EPS | 43.48% | -144.23% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.38% | -0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||